EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 ON PANCREATIC BETA-CELLS ACCELERATES BETA-CELL DESTRUCTION BY CYTOTOXIC T-CELLS IN MURINE AUTOIMMUNE DIABETES
Citation
N. Yagi et al., EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 ON PANCREATIC BETA-CELLS ACCELERATES BETA-CELL DESTRUCTION BY CYTOTOXIC T-CELLS IN MURINE AUTOIMMUNE DIABETES, Diabetes, 44(7), 1995, pp. 744-752
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
SICI code
0012-1797(1995)44:7<744:EOIMOP>2.0.ZU;2-H
Abstract
Intercellular adhesion molecule 1 (ICAM-1) plays an important role in
the pathogenesis of insulin-dependent diabetes mellitus (IDDM) by bein
g involved in the extravasation of lymphocytes from the circulation in
to the inflamed pancreas. However, the mechanism of beta-cell destruct
ion by which expression of ICAM-1 on beta-cells may facilitate adhesio
n of effector cells still remains to be elucidated Several Lines of ev
idence suggest that this adhesion molecule is involved in the destruct
ion of pancreatic beta-cells by killer lymphocytes in the NOD mouse, w
hich shows an autoimmune diabetic syndrome similar to that of human ID
DM. Immunohistochemical study under Light microscopy demonstrated that
all of the mononuclear cells infiltrating the islets strongly express
ed ICAM-1 and leukocyte function-associated antigen 1 (LFA-1), a count
erreceptor of ICAM-1, whereas ICAM-1 expression on islet cells was not
apparent. However, immunohistochemical staining under electron micros
copy revealed that islet beta-cells adjacent to infiltrating lymphocyt
es were clearly stained by an anti-ICAM-1 monoclonal-antibody (mAb). F
low cytometric analysis showed that the ICAM-1 expression on NOD islet
cells and NOD-derived insulinoma cells (MIN6N8a) was inducible by int
erferon (IFN)-gamma or tumor necrosis factor-alpha. These cytokines' h
ad an additive effect on the ICAM-I induction. Susceptibility of MIN6N
8a cells to lysis by a NOD islet-derived CD8(+) cytotoxic T-cell clone
was greatly enhanced by IFN-gamma pretreatment, and this enhancement
was abolished by anti-ICAM-1 and anti-LFA-1 mAbs. When both mAbs were
administered into NOD mice with spontaneous or adoptively transferred
diabetes, the development of diabetes was significantly prevented.